Director, Hemostasis and Thrombosis Program
Professor of Pediatrics
Keck School of Medicine of USC
Children’s Hospital Los Angeles
Los Angeles, CA

Guy Young, MD, is the Director of the Hemostasis and Thrombosis Center and the Clinical CoagulationLaboratory at Children’s Hospital Los Angeles and a professor of pediatrics at the University of SouthernCalifornia’s Keck School of Medicine. Dr. Young has published many journal articles, abstracts, andtextbook chapters and has delivered lectures, workshops, and presentations at national andinternational meetings. He is the former chair of the Scientific and Standardization Committee on FactorVIII, Factor IX, and Rare Bleeding Disorders of the International Society on Thrombosis and Haemostasisand was awarded the National Hemophilia Foundation Physician of the Year Award in 2013.

Chief Medical and Informatics Officer
Innovative Hematology, Inc.
Indiana Hemophilia and Thrombosis Center, Inc.
Indianapolis, IN, USA

Sanjay P. Ahuja, MD, MSc, MBA, is chief medical officer at Innovative Hematology, Indiana Hemophilia and Thrombosis Center, and adjunct professor, Case Western Reserve University, Cleveland, Ohio. Dr. Ahuja is well published in the field of hemostasis and thrombosis, and his clinical and translational research program focuses on development of novel coagulation assays for bleeding disorders and complex hemostatic abnormalities in critically ill patients, early and late phase clinical trials for novel therapies in hemophilia, and gene therapy in hemophilia trials, including phase 1 studies for in vivo CRISPR/CAS9 gene insertion for hemophilia B. He is funded by the Department of Defense for development of TraumaChek and the Patient-Centered Outcomes Research Institute for outcomes research in hemophilia. He holds patents for microfluidic assays in coagulation. Dr. Ahuja is a voting member of the Blood Products Advisory committee at the US Food and Drug Administration.

Director, Hemophilia Treatment Center
Chief, Pediatric Hematology
Mississippi Center for Advanced Medicine (MCAM)
Louisiana Center for Advanced Medicine (LCAM)
New Orleans, LA, USA

Tammuella Chrisentery-Singleton, MD, as the chief science officer for the American Thrombosis and Hemostasis Network (ATHN), works at the strategic and policy level to inform the scientific direction of ATHN. She works across the organization to define, develop, and implement ATHN’s science and research capabilities as well as to ensure ATHN’s commitment to public health. Additionally, she cares for adult and pediatric hematology patients at the Ochsner Center for Hemostasis and Thrombosis.

Dr. Singleton’s areas of special interest include sickle cell disease, rare blood disorders, gene therapy, and musculoskeletal ultrasound in patients with hemophilia. She has authored numerous publications and led more than 60 clinical trials and research studies—including serving as the principal investigator for ATHN 16: Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients with Hemophilia A or B with Inhibitors and ATHNTranscends: A Natural History Cohort Study.